| Literature DB >> 24563851 |
Nikoletta Papaevgeniou1, Niki Chondrogianni1.
Abstract
Protein degradation constitutes a major cellular function that is responsible for maintenance of the normal cellular physiology either through the degradation of normal proteins or through the elimination of damaged proteins. The Ubiquitin-Proteasome System (UPS)(1) is one of the main proteolytic systems that orchestrate protein degradation. Given that up- and down- regulation of the UPS system has been shown to occur in various normal (such as ageing) and pathological (such as neurodegenerative diseases) processes, the exogenous modulation of the UPS function and activity holds promise of (a) developing new therapeutic interventions against various diseases and (b) establishing strategies to maintain cellular homeostasis. Since the proteasome genes are evolutionarily conserved, their role can be dissected in simple model organisms, such as the nematode, Caenorhabditis elegans. In this review, we survey findings on the redox regulation of the UPS in C. elegans showing that the nematode is an instrumental tool in the identification of major players in the UPS pathway. Moreover, we specifically discuss UPS-related genes that have been modulated in the nematode and in human cells and have resulted in similar effects thus further exhibiting the value of this model in the study of the UPS.Entities:
Keywords: C. elegans; EGF, Epidermal Growth Factor; IIS, insulin/IGF-1 signaling pathway; Proteasome regulation; Protein; UPS, Ubiquitin–Proteasome System; Ubiquitin-proteasome system (UPS)
Mesh:
Substances:
Year: 2014 PMID: 24563851 PMCID: PMC3926112 DOI: 10.1016/j.redox.2014.01.007
Source DB: PubMed Journal: Redox Biol ISSN: 2213-2317 Impact factor: 11.799
The orthologues of the human 20S proteasome subunits in C. elegans.
The orthologues of the human 19S proteasome subunits in C. elegans. The ATPases are shown in green background.
Ubiquitin-conjugating enzymes (E2), UBCs, their orthologues in humans and the observed phenotype in C. elegans upon RNAi treatment or in mutants.
| WT | |||
| Embryonic and larval lethality with defects in sarcomere assembly | |||
| WT | |||
| WT | |||
| WT | |||
| WT | |||
| Deficiencies in embryogenesis, larval development, vulval development, posterior morphogenesis and DNA damage response | |||
| Deficiencies in embryogenesis and terminal hypodermal differentiation, embryonic arrest, vulval eversion at L4 stage, defective alae | |||
| Embryonic lethality and reduced brood size | |||
| Embryonic lethality at a stage after gastrulation but prior to muscle twitching, and abnormal larval tail morphology | |||
| WT | |||
| WT | |||
| WT | |||
| Reduced growth rate and brood size | |||
| Unhealthy larvae | |||
| Late larval arrest and reduced brood size | |||
| WT | |||
| WT | |||
| WT | |||
| Reduced fat content-lipid metabolism | |||
| Defective postembryonic neuromuscular function | |||
| – | |||
HECT-domain ubiquitin ligases in C. elegans.
| WT | ||
| Deficiencies in germline development | ||
| WT | ||
| WT | ||
| WT | ||
| WT | ||
| Embryonic lethality | ||
| Low range embryonic lethality | ||
| WT |
DUBs genes and their catalytic cores in C. elegans.
Fig. 1Genes, pathways and compounds that have been identified to alter the UPS function in C. elegans. Factors that have been revealed to alter the UPS function in C. elegans in terms of proteasome activities and/or assembly and/or expression. These factors include different molecular pathways and natural or chemical compounds along with alterations in the various components of the UPS system (e.g. proteasome subunits, E2 and E3 ligases, DUBs). Positive regulators are shown in green whereas negative regulators are shown in red. The regulators that have been shown to be redox sensitive are underlined.